GLP-1 Fusionsproteine

European patent · EP1724284 · Deleted

Register entry

Publication number
EP1724284
Application number
EP06118975
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Nov 29, 2001
Published
Nov 22, 2006
Granted
Jul 29, 2009
Deleted
Nov 29, 2021
Reason
Maximum term reached
IPC classes
C07K 14/605 (2006.01)
C07K 14/765 (2006.01)
C12N 15/62 (2006.01)
A61K 38/38 (2006.01)
A61K 38/26 (2006.01)
C07K 19/00 (2006.01)
A61P 3/10 (2006.01)
Priority
US 251954 P 07.12.2000
Divided from
EP01995845
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 29, 2021

    Maximum term reached

    Published in Swissreg on 29.11.2021

  2. Jul 29, 2009

    Granted

    Published in Swissreg on 29.07.2009

  3. Jul 29, 2009

    Agent entered

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich

    Published in Swissreg on 29.07.2009

Parties

Holder

Eli Lilly & Company

Lilly Corporate Center, Indianapolis, IN 46285, US

Agent

E. Blum & Co. AG

E. Blum & Co. AG Patent- und Markenanwälte VSP

Vorderberg 11, 8044 Zürich

Inventor

Glaesner, Wolfgang

Indianapolis, IN 46254, US

Micanovic, Radmila

Indianapolis, IN 46236, US

Tschang, Sheng-Hung Rainbow

Carmel, IN 46033, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.